Brief: Virios Therapeutics Announces Q1 2023 Financial Results

Dogwood Therapeutics

11/05/2023 13:24

May 11 (Reuters) - Virios Therapeutics Inc  VIRI.O :
    * VIRIOS THERAPEUTICS ANNOUNCES FIRST QUARTER 2023 FINANCIAL
RESULTS
    * VIRIOS THERAPEUTICS INC - NET LOSS FOR Q1 OF 2023 WAS
$0.08
BASIC AND DILUTED NET LOSS PER SHARE
    * VIRIOS THERAPEUTICS - BELIEVES IT WILL HAVE SUFFICIENT
RESOURCES
TO SUPPORT GENERAL RESEARCH AND DEVELOPMENT AND ADMINISTRATIVE
OPERATIONS INTO Q2 OF 2024
    * VIRIOS THERAPEUTICS INC - FUTURE IMC-1 FM RESEARCH OR
CLINICAL
TRIALS WILL REQUIRE ADDITIONAL FUNDING, LICENSING OR PARTNERSHIP
COLLABORATION

Source text for Eikon:  ID:nGNX3qnxQv 
Further company coverage:  VIRI.O 

 ((Reuters.Briefs@thomsonreuters.com;))